Zomedica Corp.
ZOM was delisted on the 4th of March, 2025.
93 hedge funds and large institutions have $17.7M invested in Zomedica Corp. in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 12 closing their positions.
80% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 10
42% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 12
26% more capital invested
Capital invested by funds: $14.1M → $17.7M (+$3.66M)
6% more funds holding
Funds holding: 88 → 93 (+5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Connective Capital Management
Palo Alto,
California
|
+$211K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$143K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$84.3K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$74K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$55K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ProShare Advisors
Bethesda,
Maryland
|
-$72.8K |
| 2 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
-$19.1K |
| 3 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$9.02K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$6.14K |
| 5 |
HF
HRT Financial
New York
|
-$5.86K |
ZOM Hedge Fund Activity: Q4 2023 in Review
93 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q4 2023, worth a combined $17.7M — up 26% from $14.1M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new ZOM positions and 12 closed out — a net gain of 5 holders — while 18 added to existing stakes and 10 trimmed.
The largest buyer was Connective Capital Management, opening a new position worth an estimated $211K. The largest seller was ProShare Advisors, cutting an estimated $72.8K.
- 93 institutional investors held Zomedica Corp. (ZOM) as of Q4 2023, up from 88 in Q3 2023.
- Funds reported $17.7M of Zomedica Corp. stock for Q4 2023, up 26% quarter-over-quarter.
- 17 funds opened new Zomedica Corp. positions in Q4 2023 and 12 closed out, a net change of +5 holders.
- The largest Zomedica Corp. buyer in Q4 2023 was Connective Capital Management, an estimated $211K added.
- The largest Zomedica Corp. seller in Q4 2023 was ProShare Advisors, an estimated $72.8K sold.
Based on aggregated 13F filings for Q4 2023.